Exclusive: Two Sacklers behind OxyContin maker to appear before U.S. House panel-congressional memo

By Mike Spector (Reuters) - Two Sackler family members who previously served on the board of OxyContin maker Purdue Pharma LP have agreed to appear before a U.S. House of Representatives committee examining the nationwide opioid epidemic, avoiding subpoenas threatened by the panel's chair, according to a congressional memo reviewed by Reuters. David and Kathe Sackler reached an agreement in recent days with the House Oversight Committee to testify at the hearing, currently set for Thursday, according to a memo dated on Monday outlining the plan to members of the House panel from Democratic Chairwoman Carolyn Maloney

Reuters December 15, 2020 00:11:34 IST
Exclusive: Two Sacklers behind OxyContin maker to appear before U.S. House panel-congressional memo

Exclusive Two Sacklers behind OxyContin maker to appear before US House panelcongressional memo

By Mike Spector

(Reuters) - Two Sackler family members who previously served on the board of OxyContin maker Purdue Pharma LP have agreed to appear before a U.S. House of Representatives committee examining the nationwide opioid epidemic, avoiding subpoenas threatened by the panel's chair, according to a congressional memo reviewed by Reuters.

David and Kathe Sackler reached an agreement in recent days with the House Oversight Committee to testify at the hearing, currently set for Thursday, according to a memo dated on Monday outlining the plan to members of the House panel from Democratic Chairwoman Carolyn Maloney. The two are among the Sackler family members who own Purdue Pharma.

Purdue Chief Executive Craig Landau is also slated to testify at the hearing, according to the memo.

In a statement, Purdue confirmed that Landau agreed to testify, adding that the company has "consistently cooperated" with the committee. Landau's testimony will include steps that Purdue is taking to address the opioid crisis, which includes a proposal to settle widespread litigation from U.S. communities that it values at more than $10 billion, the company said.

Representatives for the two Sacklers did not immediately respond to requests for comment.

The opioid epidemic has claimed the lives of roughly 450,000 people in the United States since 1999 due to overdoses from prescription painkillers and illegal substances such as heroin and fentanyl, constituting an enduring public health crisis. Purdue reaped more than $30 billion from opioid sales over the years that enriched Sackler family members, and the company also funneled illegal kickbacks to doctors and pharmacies, investigations have found.

The scheduled hearing follows a far-reaching U.S. Justice Department settlement with the Sacklers and Purdue in October that faced criticism from Democrats on Capitol Hill and state attorneys general suing the company and its owners over the opioid crisis.

The Democratic lawmakers and the state attorneys general have said the deal failed to hold the Sacklers more accountable and faulted its endorsement of a Purdue bankruptcy plan to restructure it as a public benefit company. The envisioned new entity, while no longer controlled by the Sacklers, would still sell OxyContin, the company's addictive prescription painkiller that has figured prominently in the opioid epidemic.

Purdue in November pleaded guilty to criminal charges over its handling of OxyContin, which included defrauding the U.S. Drug Enforcement Administration and paying illegal kickbacks to doctors and a healthcare records vendor, all to help keep opioid prescriptions flowing. The plea deal was part of a broader settlement allowing the company to effectively sidestep paying billions of dollars in penalties.

Sackler family members agreed to pay $225 million to resolve Justice Department civil claims that they disputed. They were not criminally charged.

(Reporting by Mike Spector in New York; Editing by Daniel Wallis and Will Dunham)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.